The role of maintenance therapy and novel taxanes in ovarian cancer-Reference-Cited by-同舟云学术

The role of maintenance therapy and novel taxanes in ovarian cancer

Published:2006-08 Issue:2 Volume:102 Page:218-225
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Herzog Thomas J.,Coleman Robert L.,Markman Maurie,Cella David,Thigpen J. Tate

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology,Oncology

Reference51 articles.

1. Cancer Facts and Figures. 2005, American Cancer Society.

2. Phase III randomized trial of 12 versus 3 months of maintenance paclitaxel in patients with advanced ovarian cancer after complete response to platinum and paclitaxel-based chemotherapy: a Southwest Oncology Group and Gynecologic Oncology Group trial;Markman;J. Clin. Oncol.,2003

3. Cyclophosphamide and cisplatin versus paclitaxel and cisplatin: a phase III randomized trial in patients with suboptimal stage III/IV ovarian cancer (from the Gynecologic Oncology Group);McGuire;Semin. Oncol.,1996

4. Randomized intergroup trial of cisplatin-paclitaxel versus cisplatin–cyclophosphamide in women with advanced epithelial ovarian cancer: three-year results;Piccart;J. Natl. Cancer Inst.,2000

5. Maintenance therapy in advanced ovarian cancer: progression-free survival and clinical benefit;Ozols;J. Clin. Oncol.,2003

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The use of immunotherapy for treatment of chemoresistant ovarian cancer;Overcoming Ovarian Cancer Chemoresistance;2021

2. Maintenance monotherapy with gemcitabine after standard platinum-based chemotherapy in patients with advanced urothelial cancer;International Journal of Urology;2015-02-28

3. Quality of Life in Patients with Ovarian Cancer;Advances in Diagnosis and Management of Ovarian Cancer;2013-10-22

4. A randomized phase II trial of maintenance therapy with Sorafenib in front-line ovarian carcinoma;Gynecologic Oncology;2013-07

5. Latest research and treatment of advanced-stage epithelial ovarian cancer;Nature Reviews Clinical Oncology;2013-02-05